Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
AQUINOX PHARMACEUTICALS (AQXP)
Last aquinox pharmaceuticals earnings: 11/8 09:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.aqxpharma.com/investor-relations
Company Research
Source: GlobeNewswire
• Combined company capitalized with approximately $65M to develop novel immunotherapies Neoleukin is a biopharmaceutical company creating next generation immunotherapies using de novo protein design technology. • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/IL-15 agonist with favorable therapeutic index • Conference call on August 6, 2019 at 9 a.m. EDT / 6 a.m. PDT VANCOUVER, British Columbia and SEATTLE, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP) and Neoleukin Therapeutics, Inc. (“Neoleukin”), a privately held biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that the two companies e
Show less
Read more
Impact Snapshot
Event Time:
AQXP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AQXP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AQXP alerts
High impacting AQUINOX PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics